{
    "id": 11336,
    "fullName": "ATIC - ALK",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "ATIC-ALK results from the fusion of ATIC and ALK, demonstrating elevated Alk phosphorylation and transforming ability in culture (PMID: 10706082). ATIC-ALK fusion has been identified in anaplastic large cell lymphoma (PMID: 10706082, PMID: 10702393).",
            "references": [
                {
                    "id": 3593,
                    "pubMedId": 10706082,
                    "title": "A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/10706082"
                },
                {
                    "id": 5461,
                    "pubMedId": 10702393,
                    "title": "ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/10702393"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 471,
        "geneSymbol": "ATIC",
        "terms": [
            "ATIC",
            "AICAR",
            "AICARFT",
            "HEL-S-70p",
            "IMPCHASE",
            "PURH"
        ]
    },
    "variant": "ATIC - ALK",
    "createDate": "09/03/2015",
    "updateDate": "04/02/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 238,
                "geneSymbol": "ALK",
                "terms": [
                    "ALK",
                    "CD246",
                    "NBLST3"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 12939,
            "approvalStatus": "Guideline",
            "evidenceType": "Diagnostic",
            "efficacyEvidence": "ATIC-ALK fusions aid the diagnosis of inflammatory myofibroblastic tumor (NCCN.org).",
            "molecularProfile": {
                "id": 11385,
                "profileName": "ATIC - ALK"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 50905,
                "name": "inflammatory myofibroblastic tumor",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 11385,
            "profileName": "ATIC - ALK",
            "profileTreatmentApproaches": [
                {
                    "id": 16888,
                    "name": "ALK Inhibitor",
                    "profileName": "ATIC - ALK"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}